Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11.2M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$42.6M
-
Value change
-
-$1.72M
-
Number of buys
-
11
-
Number of sells
-
-19
-
Price
-
$1.34
Significant Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q2 2025
50 filings reported holding IKNA - Ikena Oncology, Inc. - Common Stock, $0.001 par value as of Q2 2025.
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.02M shares), Blue Owl Capital Holdings LP (4.09M shares), BML Capital Management, LLC (4.03M shares), BVF INC/IL (4.01M shares), ORBIMED ADVISORS LLC (3.54M shares), Deep Track Capital, LP (2.52M shares), Omega Fund Management, LLC (2.25M shares), VANGUARD GROUP INC (1.41M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (800K shares), and NEA Management Company, LLC (600K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.